In 2024, the pharmaceutical packaging sector is anticipated to reach a substantial valuation of US$ 108.9 billion. Projections indicate a noteworthy growth trajectory, with demand expected to escalate at a compounded annual growth rate (CAGR) of 6.4% between 2024 and 2034. By the end of this period, the global pharmaceutical packaging market is forecasted to soar to an impressive US$ 214.7 billion. This surge in demand reflects the industry’s continuous expansion and adaptation to evolving needs, underlining the pivotal role of packaging in ensuring the safety, efficacy, and accessibility of pharmaceutical products worldwide.
Pharmaceutical packaging refers to packaging solutions used to pack medicinal products to protect them from external factors, increase their shelf life, and maintain their integrity. These medicinal packaging solutions are generally made from materials such as plastic, paper, metal, and glass.
Growing demand for pharmaceutical products due to increasing prevalence of various diseases and rising health awareness is a key factor driving the global pharmaceutical packaging Industry forward.
Subsequently, innovation in packaging such as development of eco-friendly and sustainable pharmaceutical packaging will boost the market during the projection period.
Packaging of the pharmaceutical products is a key concern for drug manufacturers and consumers. Any negligence in packaging material or technologies can have devastating results. As a result, companies choose safe and effective packaging solutions for their medicinal products.
Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-6150
Pharmaceutical packaging protects drugs or medications from spoilage, leakage, and contamination. It is easy-to-use & easy-to-dispose and helps pharmaceutical companies to significantly enhance life of drugs by maintaining their integrity.
Packaging solutions for pharmaceutical products include primary packaging such as bottles, vials, ampoules, blisters, and several others, as well as secondary packaging like boxes and cartons.
The recent exponential growth in sales of pharmaceutical packaging solutions is related to the rising need for child-resistant packaging formats to prevent children from suddenly consuming excessive amounts of medicine in absence of parents.
Pharmaceutical packaging has grown in popularity over the past few years since it provides safe and secure packaging solutions for a variety of pharmaceutical products, such as drugs or medications. Growing production and consumption of pharmaceuticals will eventually boost pharmaceutical packaging sales during the forecast period.
Future Market Insights anticipates that there will be ample opportunities for the manufacturers of pharmaceutical packaging during the projection period due to rising spending on pharmaceutical products across the world.
Business Growth Drivers:
- Increasing Pharmaceutical Production: With the rise in global population and healthcare needs, there’s a continuous increase in pharmaceutical production, which directly drives the demand for pharmaceutical packaging.
- Stringent Regulations: Regulatory authorities across the globe enforce stringent regulations regarding pharmaceutical packaging to ensure product safety, tamper-evidence, and patient compliance. This drives innovation and adoption of advanced packaging solutions.
- Focus on Patient Safety: There’s a growing focus on patient safety and convenience, leading to the adoption of packaging solutions that enhance drug administration accuracy, such as unit-dose packaging and child-resistant packaging.
- Technological Advancements: Innovations in packaging materials, such as smart packaging, active packaging, and anti-counterfeiting technologies, are driving market growth by offering improved product protection and extended shelf life.
- Increasing Chronic Diseases: The rise in chronic diseases globally necessitates higher consumption of pharmaceuticals, thereby boosting the demand for innovative packaging solutions to ensure product efficacy and patient compliance.
- Expansion of Generic Drugs Market: The growing market for generic drugs, especially in emerging economies, fuels the demand for cost-effective and efficient packaging solutions to maintain product integrity and meet regulatory requirements.
- Shift Towards Sustainable Packaging: Environmental concerns and regulatory pressure are driving the adoption of sustainable packaging solutions in the pharmaceutical industry, such as biodegradable materials and eco-friendly packaging designs.
Industry Restraints:
- Cost Constraints: The high initial cost associated with implementing advanced packaging technologies and complying with regulatory standards can pose a significant challenge, especially for small and medium-sized pharmaceutical companies.
- Counterfeiting Concerns: Counterfeiting of pharmaceutical products remains a significant challenge, requiring continuous investment in anti-counterfeiting technologies, which adds to the overall packaging costs.
- Complex Regulatory Landscape: Dealing with complex and evolving regulatory requirements across different regions and countries can increase compliance costs and create barriers to market entry for pharmaceutical packaging companies.
- Fragmented Market: The pharmaceutical packaging industry is highly fragmented, with numerous players operating in the market, leading to intense competition and pricing pressures.
- Logistical Challenges: Ensuring the integrity of pharmaceutical products during transportation and storage, especially for temperature-sensitive drugs, presents logistical challenges that require specialized packaging solutions and distribution processes.
- Limited Shelf Life of Pharmaceuticals: Some pharmaceutical products have short shelf lives, requiring packaging solutions that offer effective barrier properties and stability over time, which can be technically challenging and costly to achieve.
- Resistance to Innovation: Adoption of new packaging technologies may face resistance from traditionalists within the industry due to concerns regarding compatibility with existing manufacturing processes, validation requirements, and potential disruptions to supply chains.
Key Takeaways from Pharmaceutical Packaging Market
- By product type, the bottles segment is forecast to hold more than 31.3% of the value share by the end of 2033.
- Based on material type, plastics segment is projected to increase at a CAGR of 7.6% during the forecast period, creating an incremental opportunity of US$ 67.4 billion by the end of 2033.
- North America pharmaceutical packaging market is expected to expand by 2.1x of its current market value through 2033.
- With rising consumption of pharmaceutical products as well as expansion of the pharmaceutical sector, Asia Pacific Excluding Japan (APEJ) market is anticipated to expand by 2.6x of current market value by 2033.
- The USA is forecast to account for around 95.1% share of North America pharmaceutical packaging industry by the end of 2033.
“Growing need for protecting medicinal products from physical, biological, and chemical factors as well as to maintain their integrity is expected to generate lucrative prospects for the global pharmaceutical packaging market during the forecast period. Besides this, development of sustainable pharmaceutical packaging will bode well for the market,” says an FMI analyst.
Request Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-6150
Who is Winning?
- Amcor Plc
- Ardagh Group S.A.
- Becton, Dickinson and Company
- Berry Global Group, Inc.
- Bilcare Limited
- Catalent, Inc.
- Clondalkin Group Holdings B.V.
- Constantia Flexibles Group GmbH
- Gerresheimer AG
- Klöckner Pentaplast Group
- Mondi Group
- Nipro Corporation
- Piramal Glass Private Limited
- Schott AG
- Sealed Air Corporation
- Uflex Ltd.
- others
Ardagh Group S.A., Amcor plc, Becton, Dickinson and Company, Berry Global Group, Inc., Westrock Company, and Mondi group, are the top pharmaceutical packaging manufacturers operating in the global market. As per FMI’s latest analysis, around 70% to 80% of the global market is expected to be held by Tier 3 players. Subsequently, key players contribute around 20 to 30% of the global market.
Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/6150
Key Segmentations:
By Product Type:
- Bottles
- Packer Bottles
- Liquid Bottles
- Vials & Ampoules
- Blisters
- Bags & Pouches
- Prefilled Syringes & cartridges
- Sachets
- Trays
- Tubes
- Containers, Jars, & Others
By Material Type:
- Plastics
- Polyethylene
- LDPE
- HDPE
- Polyvinyl Chloride
- Polypropylene
- Polystyrene
- Polyethylene Terephthalate
- Others (Polycarbonate)
- Polyethylene
- Glass
- Metals
- Paper
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
